---
figid: PMC8038573__ijms-22-03765-g002
figlink: pmc/articles/PMC8038573/figure/ijms-22-03765-f002/
number: F2
caption: 'Anti-angiogenic drugs can act as decoy agents, monoclonal antibodies, or
  tyrosine kinase inhibitors. Bevacizumab was the first anti-angiogenic drug approved
  for human use, however, its use as monotherapy is inefficient. Compensatory mechanisms
  of other angiogenic mediators induces a switch in the vascular endothelial growth
  factor (VEGF)-dependent state to a VEGF-independent angiogenic process and leads
  to patient resistance to VEGF signaling pathway blockade. Nowadays, a new class
  of drugs, by blocking other effectors in angiogenic signaling pathways, try to improve
  the clinical efficacy of anti-angiogenic therapies. In some scenarios, the use of
  anti-angiogenic therapies delays the disease outcome of cancer patients, still other
  patients do not have any additional benefits. The major signaling pathways downstream
  of VEGFRs, FGFRs, PDGRs, and c-MET in endothelial cells (ECs) are PI3K-AKT-mTOR,
  Ras-Raf-MEK-ERK, and JAK-STATs, which are pivotal for EC survival, proliferation,
  and migration. AKT: Protein kinase B; ERK: Extracellular-signal-regulated kinase;
  FGF: Fibroblast growth factor; FGFR: Fibroblast growth factor receptor; HGF: Hepatocyte
  growth factor; JAK: Janus protein tyrosine kinase; MEK: Mitogen-activated protein
  kinase; mTOR: Mammalian target of rapamycin; PDGF: Platelet-derived growth factor;
  PDGFR: Platelet-derived growth factor receptor; PI3K: Phosphoinositide 3-kinases;
  Raf: Serine/Threonine Kinase; STAT: Signal transducer and activator of transcription
  protein; VEGF: Vascular endothelial growth factor; VEGFR: Vascular endothelial growth
  factor receptor.'
pmcid: PMC8038573
papertitle: 'Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.'
reftext: Filipa Lopes-Coelho, et al. Int J Mol Sci. 2021 Apr;22(7):3765.
pmc_ranked_result_index: '24522'
pathway_score: 0.7624959
filename: ijms-22-03765-g002.jpg
figtitle: Anti-angiogenic drugs can act as decoy agents, monoclonal antibodies, or
  tyrosine kinase inhibitors
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8038573__ijms-22-03765-g002.html
  '@type': Dataset
  description: 'Anti-angiogenic drugs can act as decoy agents, monoclonal antibodies,
    or tyrosine kinase inhibitors. Bevacizumab was the first anti-angiogenic drug
    approved for human use, however, its use as monotherapy is inefficient. Compensatory
    mechanisms of other angiogenic mediators induces a switch in the vascular endothelial
    growth factor (VEGF)-dependent state to a VEGF-independent angiogenic process
    and leads to patient resistance to VEGF signaling pathway blockade. Nowadays,
    a new class of drugs, by blocking other effectors in angiogenic signaling pathways,
    try to improve the clinical efficacy of anti-angiogenic therapies. In some scenarios,
    the use of anti-angiogenic therapies delays the disease outcome of cancer patients,
    still other patients do not have any additional benefits. The major signaling
    pathways downstream of VEGFRs, FGFRs, PDGRs, and c-MET in endothelial cells (ECs)
    are PI3K-AKT-mTOR, Ras-Raf-MEK-ERK, and JAK-STATs, which are pivotal for EC survival,
    proliferation, and migration. AKT: Protein kinase B; ERK: Extracellular-signal-regulated
    kinase; FGF: Fibroblast growth factor; FGFR: Fibroblast growth factor receptor;
    HGF: Hepatocyte growth factor; JAK: Janus protein tyrosine kinase; MEK: Mitogen-activated
    protein kinase; mTOR: Mammalian target of rapamycin; PDGF: Platelet-derived growth
    factor; PDGFR: Platelet-derived growth factor receptor; PI3K: Phosphoinositide
    3-kinases; Raf: Serine/Threonine Kinase; STAT: Signal transducer and activator
    of transcription protein; VEGF: Vascular endothelial growth factor; VEGFR: Vascular
    endothelial growth factor receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FLT1
  - KDR
  - FLT4
  - FGFR4
  - FGFRL1
  - FGFR1
  - FGFR3
  - FGFR2
  - MET
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - HRAS
  - KRAS
  - NRAS
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - AKT2
  - AKT3
  - AKT1
  - ARAF
  - BRAF
  - RAF1
  - MTOR
  - MAP2K1
  - MAP2K2
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - HGF
  - MAPK3
  - MAPK1
  - FGF1
  - FGF7
  - FGF8
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF23
  - FGF18
  - FGF20
  - FGF22
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF9
  - FGF17
  - FGF16
  - FGF19
  - FGF21
  - PDGFB
  - PDGFA
  - PDGFC
  - PDGFD
  - Nintedanib
  - Dovitinib
  - tyrosine
genes:
- word: VEGFR1
  symbol: VEGFR1
  source: hgnc_alias_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: VEGFR3
  symbol: VEGFR3
  source: hgnc_alias_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: c-MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
chemicals:
- word: Nintedanib
  source: MESH
  identifier: C530716
- word: Dovitinib
  source: MESH
  identifier: C500007
- word: tyrosine
  source: ''
  identifier: ''
diseases: []
figid_alias: PMC8038573__F2
redirect_from: /figures/PMC8038573__F2
figtype: Figure
---
